Ellen Ingalla

1.3k total citations
12 papers, 339 citations indexed

About

Ellen Ingalla is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ellen Ingalla has authored 12 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ellen Ingalla's work include Estrogen and related hormone effects (6 papers), Advanced Breast Cancer Therapies (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Ellen Ingalla is often cited by papers focused on Estrogen and related hormone effects (6 papers), Advanced Breast Cancer Therapies (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Ellen Ingalla collaborates with scholars based in United States, Switzerland and Germany. Ellen Ingalla's co-authors include Wayne J. Fairbrother, Deepak Sampath, Jason Oeh, Sophie Maïga, Joel Johansson, Elizabeth A. Punnoose, Franklin Peale, Walter C. Darbonne, Martine Amiot and Lisa D. Belmont and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Ellen Ingalla

11 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen Ingalla United States 5 241 127 126 69 49 12 339
Luke B. Fletcher United States 8 168 0.7× 121 1.0× 64 0.5× 71 1.0× 42 0.9× 16 328
Mecide Gharibo United States 12 175 0.7× 146 1.1× 197 1.6× 57 0.8× 71 1.4× 34 400
Taku Tsukamoto Japan 10 162 0.7× 99 0.8× 116 0.9× 43 0.6× 83 1.7× 50 304
Jessica Haug United States 10 303 1.3× 244 1.9× 141 1.1× 57 0.8× 57 1.2× 23 423
Johannes M. Waldschmidt Germany 9 149 0.6× 207 1.6× 158 1.3× 36 0.5× 24 0.5× 53 310
Guilhem Couderc France 7 198 0.8× 142 1.1× 142 1.1× 31 0.4× 58 1.2× 9 371
Even H. Rustad United States 9 159 0.7× 214 1.7× 147 1.2× 39 0.6× 46 0.9× 13 306
Irene Manrique Spain 9 206 0.9× 151 1.2× 199 1.6× 32 0.5× 22 0.4× 15 384
Lenka Bešše Switzerland 12 248 1.0× 186 1.5× 121 1.0× 33 0.5× 57 1.2× 39 399
Josephine L. Klitgaard United States 7 178 0.7× 108 0.9× 133 1.1× 171 2.5× 97 2.0× 11 426

Countries citing papers authored by Ellen Ingalla

Since Specialization
Citations

This map shows the geographic impact of Ellen Ingalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Ingalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Ingalla more than expected).

Fields of papers citing papers by Ellen Ingalla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Ingalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Ingalla. The network helps show where Ellen Ingalla may publish in the future.

Co-authorship network of co-authors of Ellen Ingalla

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Ingalla. A scholar is included among the top collaborators of Ellen Ingalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Ingalla. Ellen Ingalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Ingalla, Ellen, Xiaosai Yao, Jennifer M. Giltnane, et al.. (2022). Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer. Science Translational Medicine. 14(663). eabo5959–eabo5959. 9 indexed citations
3.
Daemen, Anneleen, Jill M. Spoerke, Wei Zhou, et al.. (2020). Abstract P2-11-05: ER pathway activity signature as a biomarker for endocrine agent GDC-9545. Cancer Research. 80(4_Supplement). P2–11. 1 indexed citations
4.
Metcalfe, Ciara, Wei Zhou, Jane Guan, et al.. (2020). Abstract 3406: GDC-9545: A pure antiestrogen clinical candidate that immobilizes the estrogen receptor and profoundly alters chromatin accessibility in vivo. Cancer Research. 80(16_Supplement). 3406–3406. 4 indexed citations
5.
Metcalfe, Ciara, Wei Zhou, Jane Guan, et al.. (2019). Abstract GS3-05: Prospective optimization of estrogen receptor degradation yields ER ligands with variable capacities for ER transcriptional suppression. Cancer Research. 79(4_Supplement). GS3–5. 1 indexed citations
6.
Punnoose, Elizabeth A., Joel Johansson, Franklin Peale, et al.. (2016). Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models. Molecular Cancer Therapeutics. 15(5). 1132–1144. 223 indexed citations
7.
Ong, Christy C., Anneleen Daemen, Jason Oeh, et al.. (2016). Abstract 1803: Breast cancer cell lines with acquired resistance to selective ERα degraders (SERDs) are dependent on PI3K signaling. Cancer Research. 76(14_Supplement). 1803–1803. 1 indexed citations
8.
Du, Xiangnan, Benjamin C. Lin, Ellen Ingalla, et al.. (2014). MMP-1 and Pro-MMP-10 as Potential Urinary Pharmacodynamic Biomarkers of FGFR3-Targeted Therapy in Patients with Bladder Cancer. Clinical Cancer Research. 20(24). 6324–6335. 20 indexed citations
9.
10.
11.
Ingalla, Ellen, et al.. (2008). Could mTOR be a therapeutic target for bladder cancer. 68. 1510–1510. 1 indexed citations
12.
Yen, Lily, Zhongwei Cao, Xiuli Wu, et al.. (2006). Loss of Nrdp1 Enhances ErbB2/ErbB3–Dependent Breast Tumor Cell Growth. Cancer Research. 66(23). 11279–11286. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luke B. Fletcher Breakdown of academic impact, for papers by Mecide Gharibo Breakdown of academic impact, for papers by Taku Tsukamoto Breakdown of academic impact, for papers by Jessica Haug Breakdown of academic impact, for papers by Johannes M. Waldschmidt Breakdown of academic impact, for papers by Guilhem Couderc Breakdown of academic impact, for papers by Even H. Rustad Breakdown of academic impact, for papers by Irene Manrique Breakdown of academic impact, for papers by Lenka Bešše Breakdown of academic impact, for papers by Josephine L. Klitgaard
Rankless by CCL
2026